These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7916651)

  • 1. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
    Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
    Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
    Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
    Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
    Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells.
    Pfeffer U; Fecarotta E; Vidali G
    Cancer Res; 1995 May; 55(10):2158-65. PubMed ID: 7743517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW; Jazaeri AA; Shupnik MA
    Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells.
    Rea D; Parker MG
    Cancer Res; 1996 Apr; 56(7):1556-63. PubMed ID: 8603402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.
    Leygue E; Dotzlaw H; Watson PH; Murphy LC
    Biochem Biophys Res Commun; 1996 Nov; 228(1):63-8. PubMed ID: 8912636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
    Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
    Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.
    Park W; Choi JJ; Hwang ES; Lee JH
    Clin Cancer Res; 1996 Dec; 2(12):2029-35. PubMed ID: 9816163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors.
    Poola I; Williams DM; Koduri S; Ramprakash J; Taylor RE; Hankins WD
    Anal Biochem; 1998 May; 258(2):209-15. PubMed ID: 9570831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.
    van Dijk MA; Floore AN; Kloppenborg KI; van 't Veer LJ
    Cancer Res; 1997 Aug; 57(16):3478-85. PubMed ID: 9270016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.
    Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
    Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R
    Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma.
    Weigel RJ; Crooks DL; Iglehart JD; deConinck EC
    Cell Growth Differ; 1995 Jun; 6(6):707-11. PubMed ID: 7669725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
    Leygue E; Huang A; Murphy LC; Watson PH
    Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
    Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
    Chan CM; Dowsett M
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.